This website is sponsored by MicroTransponder. (www.microtransponder.com)

The clinical trial is supported by the National Institute on Deafness and Other Communication Disorders of the National Institutes of Health under award number U44DC010084.

MicroTransponder is a medical device company with an expert team of neuroscientists and engineers that have worked with doctors to develop a complete neurostimulation system to treat tinnitus.  Decades of neuroscience based research have led to this novel therapy for the treatment of tinnitus.